SCYNEXIS, Inc. (SCYX)

USD 0.74

(-12.33%)

Inventory Summary of SCYNEXIS, Inc.

  • SCYNEXIS, Inc.'s latest annual inventory in 2023 was - USD , down -100.0% from previous year.
  • SCYNEXIS, Inc.'s latest quarterly inventory in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • SCYNEXIS, Inc. reported annual inventory of 899 Thousand USD in 2022, up 94.17% from previous year.
  • SCYNEXIS, Inc. reported annual inventory of 463 Thousand USD in 2021, down -75.84% from previous year.
  • SCYNEXIS, Inc. reported quarterly inventory of - USD for 2024 Q2, down 0.0% from previous quarter.
  • SCYNEXIS, Inc. reported quarterly inventory of 10.29 Million USD for 2023 Q2, up 831.22% from previous quarter.

Annual Inventory Chart of SCYNEXIS, Inc. (2023 - 2012)

Historical Annual Inventory of SCYNEXIS, Inc. (2023 - 2012)

Year Inventory Inventory Growth
2023 - USD -100.0%
2022 899 Thousand USD 94.17%
2021 463 Thousand USD -75.84%
2020 1.91 Million USD 0.0%
2019 - USD -100.0%
2018 520 Thousand USD -28.28%
2017 725 Thousand USD 55.25%
2016 467 Thousand USD -3.51%
2015 484 Thousand USD -93.25%
2014 7.17 Million USD 1382.44%
2013 484 Thousand USD 17.19%
2012 413 Thousand USD 0.0%

Peer Inventory Comparison of SCYNEXIS, Inc.

Name Inventory Inventory Difference
Cosmos Health Inc. 4.78 Million USD 100.0%
Safety Shot Inc 1.86 Million USD 100.0%
Bright Green Corporation - USD NaN%
Embecta Corp. 152.1 Million USD 100.0%
ANI Pharmaceuticals, Inc. 111.19 Million USD 100.0%
Aquestive Therapeutics, Inc. 6.76 Million USD 100.0%
Collegium Pharmaceutical, Inc. 32.33 Million USD 100.0%
Dynavax Technologies Corporation 53.29 Million USD 100.0%
Esperion Therapeutics, Inc. 65.62 Million USD 100.0%
Intra-Cellular Therapies, Inc. 11.64 Million USD 100.0%
Pacira BioSciences, Inc. 104.35 Million USD 100.0%
PainReform Ltd. - USD NaN%
Sunshine Biopharma, Inc. 5.73 Million USD 100.0%
Sunshine Biopharma, Inc. 5.73 Million USD 100.0%
China SXT Pharmaceuticals, Inc. 809.75 Thousand USD 100.0%
Journey Medical Corporation 10.2 Million USD 100.0%
Alpha Teknova, Inc. 11.59 Million USD 100.0%
Procaps Group, S.A. 96.83 Million USD 100.0%
Theratechnologies Inc. 6.06 Million USD 100.0%
Harrow Health, Inc. 10.86 Million USD 100.0%
Sonoma Pharmaceuticals, Inc. 2.71 Million USD 100.0%
Biofrontera Inc. 10.9 Million USD 100.0%
DURECT Corporation 2.21 Million USD 100.0%
Supernus Pharmaceuticals, Inc. 77.4 Million USD 100.0%
Cronos Group Inc. 30.33 Million USD 100.0%
OptiNose, Inc. 8.05 Million USD 100.0%
Ironwood Pharmaceuticals, Inc. 1.00 USD 100.0%
Kala Pharmaceuticals, Inc. - USD NaN%
RedHill Biopharma Ltd. 5.69 Million USD 100.0%
Organogenesis Holdings Inc. 28.25 Million USD 100.0%
Guardion Health Sciences, Inc. 2.67 Million USD 100.0%
Cumberland Pharmaceuticals Inc. 4.6 Million USD 100.0%
Radius Health, Inc. 278.64 Million USD 100.0%
Universe Pharmaceuticals INC 3.34 Million USD 100.0%
ProPhase Labs, Inc. 3.84 Million USD 100.0%
Phibro Animal Health Corporation 265.91 Million USD 100.0%
Procaps Group S.A. 96.83 Million USD 100.0%
Alvotech 74.43 Million USD 100.0%
TherapeuticsMD, Inc. - USD NaN%
Viatris Inc. 3.46 Billion USD 100.0%
Rockwell Medical, Inc. 5.87 Million USD 100.0%
Aytu BioPharma, Inc. 12.63 Million USD 100.0%
SIGA Technologies, Inc. 64.21 Million USD 100.0%
Tilray Brands, Inc. 252.08 Million USD 100.0%
Lifecore Biomedical, Inc. 39.97 Million USD 100.0%
Shineco, Inc. 1.58 Million USD 100.0%
PetIQ, Inc. 159.3 Million USD 100.0%
Regencell Bioscience Holdings Limited -152.77 Thousand USD 100.0%
Incannex Healthcare Limited -10.01 Million USD 100.0%
Neurocrine Biosciences, Inc. 38.3 Million USD 100.0%
Alimera Sciences, Inc. 1.87 Million USD 100.0%
Silver Spike Investment Corp. - USD NaN%
Assertio Holdings, Inc. 37.68 Million USD 100.0%
Shuttle Pharmaceuticals Holdings, Inc. - USD NaN%
Petros Pharmaceuticals, Inc. 1.61 Million USD 100.0%
Clever Leaves Holdings Inc. 4.48 Million USD 100.0%
Cyclo Therapeutics, Inc. 254.35 Thousand USD 100.0%
Avadel Pharmaceuticals plc 10.38 Million USD 100.0%
Hempacco Co., Inc. 2.54 Million USD 100.0%
Talphera, Inc. - USD NaN%
Alvotech 74.43 Million USD 100.0%
Eagle Pharmaceuticals, Inc. 47.79 Million USD 100.0%
Lantheus Holdings, Inc. 64.02 Million USD 100.0%
Currenc Group, Inc. 732.91 Thousand USD 100.0%
Kamada Ltd. 87.74 Million USD 100.0%
Indivior PLC 141.79 Million USD 100.0%
Evoke Pharma, Inc. 481.84 Thousand USD 100.0%
Flora Growth Corp. 8.5 Million USD 100.0%
Cyclo Therapeutics, Inc. 254.35 Thousand USD 100.0%
Evolus, Inc. 10.99 Million USD 100.0%
HUTCHMED (China) Limited 50.25 Million USD 100.0%
Amphastar Pharmaceuticals, Inc. 105.83 Million USD 100.0%
Akanda Corp. 1.28 Million USD 100.0%